This week in cardiology from heartwire
View all posts »#180: "Choosing wisely" now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol...
Mar 1, 2013 14:30 EST-
0Comments
-
Read later
For the week ending March 1, 2013 we discuss the following top cardiology news from heartwire:
- "Choosing wisely" now targets over 130 dubious tests, therapies
- HPS2-THRIVE: High myopathy risk with niacin/laropiprant
- Unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention: PREDIMED
- Large proportion of raised LDL cholesterol in FH caused by multiple genes
And also, in brief:
- Dabigatran noninferior to warfarin for extended VTE therapy: RE-MEDY published
- Spironolactone disappoints in preserved-EF heart failure: Aldo-DHF in print
Join us for a comprehensive review of this week's most important cardiology news.
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
